×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Institute of Chi... [2]
Faculty of Healt... [2]
THE STATE KEY LA... [2]
Authors
HU YUANJIA [2]
Document Type
Journal article [1]
Review article [1]
Date Issued
2024 [1]
2023 [1]
Language
英語English [2]
Source Publication
Cancer [2]
Indexed By
SCIE [2]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-2 of 2
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
Characteristics of clinical trials of new oncology drugs approved in China
Journal article
Yang, Jing, Yang, Ji, Hu, Yuan Jia. Characteristics of clinical trials of new oncology drugs approved in China[J]. Cancer, 2024, 130(5), 671-682.
Authors:
Yang, Jing
;
Yang, Ji
;
Hu, Yuan Jia
Favorite
|
TC[WOS]:
2
TC[Scopus]:
2
IF:
6.1
/
6.7
|
Submit date：2024/05/16
Clinical Evidence
Drug Lag
Novel Anticancer Drugs
Pivotal Clinical Trials
Programmed Death-1 (Pd-1) Inhibitors
Programmed Death-ligand 1 (Pd-l1) Inhibitors
Characteristics of clinical trials of new oncology drugs approved in China
Review article
2023
Authors:
Jing Yang
;
Ji Yang
;
HU YUANJIA
Adobe PDF
|
Favorite
|
TC[WOS]:
2
TC[Scopus]:
2
IF:
6.1
/
6.7
|
Submit date：2024/01/02
Clinical Evidence
Drug Lag
Novel Anticancer Drugs
Pivotal Clinical Trials
Programmed Death-1 (Pd-1) Inhibitors
Programmed Death-ligand 1 (Pd-l1) Inhibitors
